AstraZeneca is appealing a Fair Work Commission decision that workers are guaranteed 10 days’ sick leave under the National Employment Standards regardless of how long their working day is.
The Full Federal Court will hear arguments next week in an appeal by the ACCC over an alleged laundry detergent cartel, the first so-called hub and spoke case brought by the competition regulator.
Chain logistics company Brambles is facing a second class action alleging it breached its continuous disclosure obligations by failing to revise its overly rosy 2017 financial forecast on several occasions.
A judge has denied a Westpac unit’s bid to strike allegations that it knew about a $1.9 million Ponzi scheme from a class action alleging the bank aided the Ponzi schemer’s illegal conduct.
When it comes to bet-the-company matters that keep corporate counsel awake at night, intellectual property disputes often rank at the top of the list. And these eight law firms are the ones companies turned to the most last year when facing a courtroom battle over their IP.
Slater and Gordon has filed a shareholder class action against Brambles over its allegedly misleading and overly rosy 2017 financial forecasts, beating rival Maurice Blackburn to the punch almost 10 months after it announced it was investigating a shareholder class action against the logistics company.
Ophthalmic diagnostic device manufacture ObjectiVision can’t file amended claims for damages following a trial in a copyright and contract case against the University of Sydney, with a judge saying the school would be “severely prejudiced” if the new claims were allowed.
Cargill has won court approval to amend its pleading against Viterra to include details of a law firm meeting in which Viterra executives allegedly made assurances that there were no quality issues with its malt, more than two months into the trial over the $420 million sale of Viterra’s Joe White Maltings business to Cargill in 2013.
A judge has given the green light to a settlement of seven class actions against ratings agency S&P Global over toxic financial products, saying despite an “extraordinarily large” litigation funding fee the deal was a “significant vindication” of group member claims.
The corporate watchdog can’t get its hands on documents detailing Westpac’s disciplinary measures against rogue traders or communications between the employees ahead of a penalty hearing in a case that found the bank attempted to influence the Bank Bill Swap Rate.